169
Views
3
CrossRef citations to date
0
Altmetric
Miscellany

Increased plasma concentration of 4-pyridone-3-carboxamide-1-ß-D-ribonucleoside (4PYR) in lung cancer. Preliminary studies

, , , , , , , & show all
Pages 781-787 | Received 29 Jan 2019, Accepted 25 Mar 2019, Published online: 16 Apr 2019

References

  • Dutta, S. P.; Crain, P. F.; McCloskey, J. A.; Chheda, G. B. Isolation and Characterization of 1-beta-D-Ribofuranosylpyridin-4-One-3-Carboxamide from Human Urine. Life Sci. 1979, 24, 1381–1388.
  • Rutkowski, B.; Rutkowski, P.; Słomińska, E.; Smolenski, R. T.; Swierczyński, J. Cellular Toxicity of Nicotinamide Metabolites. J. Ren. Nutr. 2012, 22, 95–97. DOI:10.1053/j.jrn.2011.10.033.
  • Vanholder, R.; De Smet, R.; Glorieux, G.; Argilés, A.; Baurmeister, U.; Brunet, P.; Clark, W.; Cohen, G.; De Deyn, P. P.; Deppisch, R.; et al. Review on Uremic Toxins: Classification, Concentration, and Interindividual Variability. Kidney Int. 2003, 63, 1934–1943. DOI:10.1046/j.1523-1755.2003.00924.x.
  • Rutkowski, P.; Maria Słomińska, E.; Szołkiewicz, M.; Aleksandrowicz, E.; Tomasz Smoleński, R.; Wołyniec, W.; Renke, M.; Wisterowicz, K.; Świerczyński, J.; Rutkowski, B.; et al. Relationship between Uremic Toxins and Oxidative Stress in Patients with Chronic Renal Failure. Scand. J. Urol. Nephrol. 2007, 41, 243–248.
  • Pelikant-Malecka, I.; Kaniewska-Bednarczuk, E.; Szrok, S.; Sielicka, A.; Sledzinski, M.; Orlewska, C.; Smolenski, R. T.; Slominska, E. M. Metabolic Pathway of 4-Pyridone-3-Carboxamide-1β- d -Ribonucleoside and Its Effects on Cellular Energetics. Int. J. Biochem. Cell. Biol. 2017, 88, 31–43.
  • Blazejczyk, A.; Switalska, M.; Chlopicki, S.; Marcinek, A.; Gebicki, J.; Nowak, M.; Nasulewicz-Goldeman, A.; Wietrzyk, J. 1-methylnicotinamide and Its Structural Analog 1,4-Dimethylpyridine for the Prevention of Cancer Metastasis. J. Exp. Clin. Cancer Res. 2016, 35, 110DOI:10.1186/s13046-016-0389-9.
  • Chlopicki, S.; Swies, J.; Mogielnicki, A.; Buczko, W.; Bartus, M.; Lomnicka, M.; Adamus, J.; Gebicki, J. 1-Methylnicotinamide (MNA), a Primary Metabolite of Nicotinamide, Exerts anti-thrombotic Activity Mediated by a Cyclooxygenase-2/Prostacyclin Pathway. Br. J. Pharmacol. 2007, 152, 230–239. DOI:10.1038/sj.bjp.0707383.
  • Bar, A.; Olkowicz, M.; Tyrankiewicz, U.; Kus, E.; Jasinski, K.; Smolenski, R. T.; et al. Functional and Biochemical Endothelial Profiling in Vivo in a Murine Model of Endothelial Dysfunction; Comparison of Effects of 1-Methylnicotinamide and Angiotensin-Converting Enzyme Inhibitor. Front. Pharmacol. 2017, 8, 183.
  • Siegel, R. L.; Miller, K. D.; Jemal, A. Cancer Statistics, 2018. CA Cancer J. Clin. 2018, 68, 7–30.
  • Olkowicz, M.; Debski, J.; Jablonska, P.; Dadlez, M.; Smolenski, R. T. Application of a New Procedure for Liquid Chromatography/Mass Spectrometry Profiling of Plasma Amino Acid-Related Metabolites and Untargeted Shotgun Proteomics to Identify Mechanisms and Biomarkers of Calcific Aortic Stenosis. J. Chromatogr. A. 2017, 1517, 66–78. DOI:10.1016/j.chroma.2017.08.024.
  • Slominska, E. M.; Carrey, E. A.; Foks, H.; Orlewska, C.; Wieczerzak, E.; Sowinski, P.; Yacoub, M. H.; Marinaki, A. M.; Simmonds, H. A.; Smolenski, R. T.; et al. A Novel Nucleotide Found in Human Erythrocytes, 4-Pyridone-3-Carboxamide-1-Beta-D-ribonucleoside Triphosphate. J. Biol. Chem. 2006, 281, 32057–32064. DOI:10.1074/jbc.M607514200.
  • Eelen, G.; de Zeeuw, P.; Simons, M.; Carmeliet, P. Endothelial Cell Metabolism in Normal and Diseased Vasculature. Circ. Res. 2015, 116, 1231–1244. DOI:10.1161/CIRCRESAHA.116.302855.
  • Notsu, Y.; Yano, S.; Shibata, H.; Nagai, A.; Nabika, T. Plasma Arginine/ADMA Ratio as a Sensitive Risk Marker for Atherosclerosis: Shimane CoHRE Study. Atherosclerosis 2015, 239, 61–66. DOI:10.1016/j.atherosclerosis.2014.12.030.
  • Visser, M.; Vermeulen, M. A. R.; Richir, M. C.; Teerlink, T.; Houdijk, A. P. J.; Kostense, P. J.; Wisselink, W.; de Mol, B. A. J. M.; van Leeuwen, P. A. M.; Oudemans-van Straaten, H. M.; et al. Imbalance of Arginine and Asymmetric Dimethylarginine Is Associated with Markers of Circulatory Failure, Organ Failure and Mortality in Shock Patients. Br. J. Nutr. 2012, 107, 1458–1465. DOI:10.1017/S0007114511004648.
  • Laurence, A.; Edbury, S. M.; Marinaki, A. M.; Smolenski, R. T.; Goldsmith, D. J. A.; Simmonds, H. A.; Carrey, E. A. 4-pyridone-3-Carboxamide Ribonucleoside Triphosphate Accumulating in Erythrocytes in End Stage Renal Failure Originates from Tryptophan Metabolism. Clin. Expermed. 2007, 7, 135–141. DOI:10.1007/s10238-007-0137-8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.